Caris Life Sciences secures up to $1.2B in new credit, including $400M immediate funding and $300M for acquisitions.

{
  "signal_id": "431f2688-5ad3-486a-86c9-a8e186d55f24",
  "signal_type": "sec-8k",
  "signal_subtype": "debtRefinancing",
  "detected_at": "2026-04-07T09:30:39.702+00:00",
  "company": {
    "name": "Caris Life Sciences",
    "domain": "carislifesciences.com"
  },
  "data": {
    "detail": "The company has raised $400M in immediate capital and has access to an additional $300M specifically earmarked for acquisitions, signaling a major growth and M&A strategy. This large influx of capital creates opportunities for significant investments in technology, integration services, and operational scaling to support future growth.",
    "metrics": {
      "timeframe": "immediate",
      "dollar_context": "Initial term loan funded from new credit agreement; company has access to an additional $300M for acquisitions and a $500M uncommitted facility.",
      "dollar_millions": 400
    },
    "summary": "Caris Life Sciences secures up to $1.2B in new credit, including $400M immediate funding and $300M for acquisitions.",
    "excerpts": "The New Credit Agreement provides for certain senior secured credit facilities to the Company consisting of (a) an initial term loan in an aggregate principal amount equal to $400,000,000, funded on the Closing Date (the “Initial Term Facility”), (b) a committed delayed draw term loan facility in an aggregate principal amount that may be drawn in one or more tranches not to exceed $300,000,000 in the aggregate (“Delayed Draw Facility”), and (c) an uncommitted incremental facility in an aggregate principal amount not to exceed $500,000,000.",
    "relevance": 0.9,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/2019410/000201941026000019/cai-20260401.htm",
    "filing_date": "2026-04-02",
    "filing_year": 2026,
    "fiscal_year_end": "04/01",
    "sales_relevance": "Capital available or pressure",
    "signal_category": "financial",
    "vendors_mentioned": [
      "Blue Owl Capital",
      "Blackstone",
      "Wilmington Trust, National Association"
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/431f2688-5ad3-486a-86c9-a8e186d55f24 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"carislifesciences.com","limit":20}'